Delivery Order SPE2DB20D1100-SPE2DB25FY78B

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $1,005.11 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 ml autoinjectors. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a $1,927.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 mL autoinjectors. The contract has an ultimate completion date of November 25, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Sumatriptan 6 mg/0.5 ml autoinjector medication. The award is from the Defense Logistics Agency (DLA), a defense agency, and has a ceiling value of $4,821.03. The contract is a delivery order and is priced on a firm fixed price basis. This award is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Sumatriptan 6 mg/0.5 ml autoinjectors. The $2,805.76 firm fixed-price contract has a completion date of June 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Sumatriptan 6 mg/0.5 ml auto-injectors. The delivery order, valued at $5,456.51, was awarded on September 27, 2024, with a completion date of September 30, 2024. This contract does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award is for the delivery of Sumatriptan 6 mg/0.5 ml auto-injectors to the Defense Logistics Agency (DLA). The $2,463.94 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024, with a period of performance through October 21, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Sumatriptan 6 mg/0.5 ml autoinjectors to support Department of Defense (DoD) healthcare programs. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,907.07 and an ultimate completion date of February 1, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,566,817,288 units of the pharmaceutical drug Sumatriptan 6 mg/0.5 mL auto-injector. The contract has a ceiling value of $2,068.86 and a completion date of January 2, 2025. It is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,653.88 firm fixed-price delivery order is for the supply of 4,565,752,700 units of the drug Sumatriptan 6 mg/0.5 ml autoinjector. The award has an ultimate completion date of September 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $4,253.97 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4,566,281,428 units of sumatriptan 6 mg/0.5 mL autoinjectors. The IDC with the DLA is valued at $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FY78B
    Delivery Order

The federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of sumatriptan 6 mg/0.5 ml autoinjectors. The contract has a ceiling value of $2,770.80 and runs through October 30, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/20/25, 1:57 PM